Schubert Center Faculty Associate Robert Findling, M.D., talks about his findings from a long-term medication treatment study of teenagers with schizophrenia and its related disorders. This study was published in the June issue of the Journal of the American Academy of Child and Adolescent Psychiatry. Dr. Findling found that only 12% of the children enrolled in his study were able to complete its 12-month duration. He reports that side effects and lack of drug efficacy were the primary reasons for withdrawing from the study. Dr. Findling concludes that children with psychotic illnesses have only a few viable treatment options available to them and that more research is necessary to develop better and safer treatments for this vulnerable population of children.
Click here to read and watch Dr. Finding discuss the results of his recently published study: Double-Blind Maintenance Safety and Effectiveness Findings From the Treatment of Early-Onset Schizophrenia Spectrum (TEOSS) Study.